News Focus
News Focus
icon url

Doc logic

08/22/23 11:15 PM

#623463 RE: Legend431 #623458

Legend431,

Merck has been awful quiet about their interest in NWBO since Mr. Duffy returned to them and then went to Regeneron who was represented at NYAS on May 10th last year. Seems Mr. Duffy learned something so important that NO ONE IS TALKING! Do you suppose Merck and Regeneron might be vetted by NWBO and all are just waiting on final clearance for takeoff?; ). Maybe some others suspect the same and aren’t happy with the way things are headed. See any issue with Pfizer, Biden administration and Citadel reps hanging out together with the Bilderbergs this year or Kenny donating all that money to Harvard?: (. Can anyone else see the light?; ). Best wishes.
icon url

Margin Buu

08/22/23 11:22 PM

#623464 RE: Legend431 #623458

NWBO gets more attention on the chat boards than Tesla and Merck. Many investors believe - based on the evidence and trial results we have seen - this company is in fact the future of cancer medicine.. NOW. This has been 20 years in the making, they know they’re going to make it with or without a PR. I’d like them to do everything in their power to not trip just before crossing the finish line. Sorry, no foothold for litigation.
icon url

aesop1

08/23/23 6:57 AM

#623488 RE: Legend431 #623458

Due dillegence or dot connecting? The level of speculation here is absurd and rarely pans out. Why would you need to speculate? Because the company fails to execute execute and guide. Vague descriptions with no timelines. Pathetic. The paid pumpers continue to give you false hope and speculation. What BP would want to partner with this POS company. Seriously. They can buy this company out for pennies if they wanted, they aren't going to partner with this lying company. This company can't EVEN submit an Application....pathetic.

Science - Decent
Mgmt - Can't execute, can't Guide, Is Vague, Lack of experience
Financials- Running on Fumes

Sorry, science ain't enough.